Myosin Therapeutics
Jupiter, US · Founded 2020 · Delaware corporation
Founders & leadership
Myosin Therapeutics was founded in 2020 by Courtney Miller.
CM
Courtney MillerFounder
PG
Patrick Griffin, Ph.D.Named on SEC filing
DA
Dave AdamsNamed on SEC filing
AR
Andrew RitterNamed on SEC filing
RF
Robert FinizioNamed on SEC filing
TK
Theodore KameneckaNamed on SEC filing
JS
Jackson StreeterNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2022
▶$3MraisedMar 2023 · 4 investors · PharmaceuticalsRule 506(b)
▶$3MraisedMar 2023 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Patrick Griffin, Ph.D.Director
- Dave AdamsDirector
- Andrew RitterDirector
- Courtney MillerExecutive Officer, Director
- Robert FinizioDirector
- Theodore KameneckaDirector
- Jackson StreeterDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapBioworld20 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Solu16 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Companies competing with Myosin Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $406.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $325.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Myosin Therapeutics?
- Myosin Therapeutics was founded by Courtney Miller in 2020.
- How much funding has Myosin Therapeutics raised?
- Myosin Therapeutics has disclosed $3M raised across 1 round.
- Where is Myosin Therapeutics headquartered?
- Myosin Therapeutics is headquartered in Jupiter, US.